Year |
Citation |
Score |
2007 |
vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Hauser R, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, ... ... Wetherill Y, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reproductive Toxicology (Elmsford, N.Y.). 24: 131-8. PMID 17768031 DOI: 10.1016/J.Reprotox.2007.07.005 |
0.388 |
|
2006 |
Wetherill YB, Hess-Wilson JK, Comstock CE, Shah SA, Buncher CR, Sallans L, Limbach PA, Schwemberger S, Babcock GF, Knudsen KE. Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer. Molecular Cancer Therapeutics. 5: 3181-90. PMID 17172422 DOI: 10.1158/1535-7163.Mct-06-0272 |
0.606 |
|
2005 |
Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Research. 65: 54-65. PMID 15665279 |
0.751 |
|
2003 |
Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE. Specificity of cyclin D1 for androgen receptor regulation. Cancer Research. 63: 4903-13. PMID 12941814 |
0.612 |
|
2002 |
Wetherill YB, Petre CE, Monk KR, Puga A, Knudsen KE. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Molecular Cancer Therapeutics. 1: 515-24. PMID 12479269 |
0.765 |
|
2002 |
Petre CE, Wetherill YB, Danielsen M, Knudsen KE. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. The Journal of Biological Chemistry. 277: 2207-15. PMID 11714699 DOI: 10.1074/Jbc.M106399200 |
0.677 |
|
Show low-probability matches. |